GT200200087A - Derivados de imidazo (1,5-a) pirimido(5,4-d) (1) benzacepina - Google Patents
Derivados de imidazo (1,5-a) pirimido(5,4-d) (1) benzacepinaInfo
- Publication number
- GT200200087A GT200200087A GT200200087A GT200200087A GT200200087A GT 200200087 A GT200200087 A GT 200200087A GT 200200087 A GT200200087 A GT 200200087A GT 200200087 A GT200200087 A GT 200200087A GT 200200087 A GT200200087 A GT 200200087A
- Authority
- GT
- Guatemala
- Prior art keywords
- derivatives
- imidaze
- benzacepin
- pyrimid
- pirimided
- Prior art date
Links
- DQFQCHIDRBIESA-UHFFFAOYSA-N 1-benzazepine Chemical compound N1C=CC=CC2=CC=CC=C12 DQFQCHIDRBIESA-UHFFFAOYSA-N 0.000 abstract 1
- 102000004300 GABA-A Receptors Human genes 0.000 abstract 1
- 108090000839 GABA-A Receptors Proteins 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE IMIDAZO(1,5A) PIRIMIDO(5,4D)(1) BENZAZEPINA DE FORMULA GENERAL (I) EN DONDE N, R1,R2,R3, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS MUESTRAN UNA ELEVADA AFINIDAD Y SELECTIVIDAD PARA LOS SITIOS DE UNION DEL RECEPTOR ALFA5 DE GABA A Y PUEDEN SER UTILES EN CUADROS DE TRASTORNOS COGNITIVOS, TALES COMO EL ALZHEIMER.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01112222 | 2001-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200200087A true GT200200087A (es) | 2003-06-19 |
Family
ID=8177471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200200087A GT200200087A (es) | 2001-05-18 | 2002-05-16 | Derivados de imidazo (1,5-a) pirimido(5,4-d) (1) benzacepina |
Country Status (38)
Country | Link |
---|---|
US (1) | US6686352B2 (es) |
EP (1) | EP1399448B1 (es) |
JP (1) | JP4068466B2 (es) |
KR (1) | KR100533406B1 (es) |
CN (1) | CN1230436C (es) |
AR (1) | AR033753A1 (es) |
AT (1) | ATE283857T1 (es) |
AU (1) | AU2002338898B2 (es) |
BG (1) | BG108369A (es) |
BR (1) | BR0209859A (es) |
CA (1) | CA2446903C (es) |
CZ (1) | CZ20033355A3 (es) |
DE (1) | DE60202147T2 (es) |
DK (1) | DK1399448T3 (es) |
EC (1) | ECSP034851A (es) |
ES (1) | ES2232778T3 (es) |
GT (1) | GT200200087A (es) |
HK (1) | HK1066544A1 (es) |
HR (1) | HRP20030890A2 (es) |
HU (1) | HUP0400743A3 (es) |
IL (2) | IL158572A0 (es) |
JO (1) | JO2297B1 (es) |
MA (1) | MA27024A1 (es) |
MX (1) | MXPA03010529A (es) |
MY (1) | MY127570A (es) |
NO (1) | NO20035104L (es) |
NZ (1) | NZ529097A (es) |
PA (1) | PA8545201A1 (es) |
PE (1) | PE20030041A1 (es) |
PL (1) | PL366846A1 (es) |
PT (1) | PT1399448E (es) |
RU (1) | RU2287531C2 (es) |
SI (1) | SI1399448T1 (es) |
SK (1) | SK15252003A3 (es) |
TW (1) | TWI251489B (es) |
WO (1) | WO2002094834A1 (es) |
YU (1) | YU90003A (es) |
ZA (1) | ZA200308544B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101748290B1 (ko) | 2004-05-14 | 2017-06-16 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 방법 |
CN101068815B (zh) * | 2004-10-04 | 2012-09-05 | 千禧药品公司 | 有效作为蛋白激酶抑制剂的内酰胺化合物 |
KR100915469B1 (ko) * | 2004-10-20 | 2009-09-03 | 에프. 호프만-라 로슈 아게 | 할로겐 치환된 벤조다이아제핀 유도체 |
NZ554439A (en) * | 2004-10-20 | 2009-09-25 | Hoffmann La Roche | Imidazo-benzodiazepine derivatives |
CA2625611A1 (en) * | 2005-10-11 | 2007-04-19 | F. Hoffman-La Roche Ag | Imidazo benzodiazepine derivatives |
PE20080145A1 (es) | 2006-03-21 | 2008-02-11 | Janssen Pharmaceutica Nv | Tetrahidro-pirimidoazepinas como moduladores de trpv1 |
CL2007003244A1 (es) | 2006-11-16 | 2008-04-04 | Millennium Pharm Inc | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. |
CL2008003749A1 (es) | 2007-12-17 | 2010-01-15 | Janssen Pharmaceutica Nv | Compuestos derivados de imidazol, oxazol, y tiazol pirimidina, moduladores de trpv1, proceso de preparacion, composicion farmaceutica y su uso en el tratamiento de enfermedades, trastornos o condicion de dolor, prurito, artritis, tos, asma, trastorno del oido interno y enfermedad inflamatoria intestinal, entre otras. |
CN101735211B (zh) * | 2008-11-04 | 2012-11-14 | 复旦大学 | 2,3-二氢[1,5]苯并噻氮杂*类化合物或其盐在制备GSK-3β抑制剂中的用途 |
AR074487A1 (es) | 2008-12-05 | 2011-01-19 | Millennium Pharm Inc | Tiolactamas inhibidoras de proteinquinasas plk, composiciones farmaceuticas que las contienen y usos de las mismas para el tratamiento de trastornos proliferativos e inflamatorios, en particular cancer. |
EP2376082B1 (en) | 2008-12-22 | 2014-03-05 | Millennium Pharmaceuticals, Inc. | Combination of aurora kinase inhibitors and anti-cd20 antibodies |
JO3635B1 (ar) | 2009-05-18 | 2020-08-27 | Millennium Pharm Inc | مركبات صيدلانية صلبة وطرق لانتاجها |
WO2011103089A1 (en) | 2010-02-19 | 2011-08-25 | Millennium Pharmaceuticals, Inc. | Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6--methoxyphenyl)-5h -pyrimido[5,4-d][2]benzazepin-2yl]amino}-2-methoxybenzoate |
CN101891706B (zh) * | 2010-04-09 | 2013-05-29 | 复旦大学 | 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途 |
CN102424670A (zh) * | 2011-10-31 | 2012-04-25 | 江苏阿尔法药业有限公司 | 一种合成3-(3-氯丙基)-1,3,4,5-四氢-7,8-二甲氧基-2h-3-苯并氮杂卓-2-酮的方法 |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
US20130303519A1 (en) | 2012-03-20 | 2013-11-14 | Millennium Pharmaceuticals, Inc. | Methods of treating cancer using aurora kinase inhibitors |
CN105209042B (zh) | 2013-03-22 | 2019-03-08 | 米伦纽姆医药公司 | 催化性mtorc 1/2抑制剂与选择性极光a激酶抑制剂的组合 |
CN106068256B (zh) | 2013-12-20 | 2020-10-23 | 艾吉因生物股份有限公司 | 用于治疗认知损害的苯并二氮杂*衍生物、组合物和方法 |
IL256354B (en) | 2015-06-19 | 2022-09-01 | Agenebio Inc | Benzodiazepine derivatives, compositions, and uses thereof for treating cognitive impairment |
US20180207173A1 (en) | 2015-07-21 | 2018-07-26 | Millennium Pharmaceuticals, Inc. | Administration of aurora kinase inhibitor and chemotherapeutic agents |
US11505555B2 (en) | 2016-12-19 | 2022-11-22 | Agenebio, Inc. | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment |
MX2020013927A (es) | 2018-06-19 | 2021-03-02 | Agenebio Inc | Derivados de benzodiazepina, composiciones y metodos para tratar el deterioro cognitivo. |
CN110452172B (zh) * | 2019-08-21 | 2021-03-26 | 爱斯特(成都)生物制药股份有限公司 | 一种苯并己内酰胺的合成方法 |
CN112159411A (zh) * | 2020-10-15 | 2021-01-01 | 南京工业大学 | 一种三氟甲基取代嘧啶并[1,3]二氮杂*化合物及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW201311B (es) | 1991-06-17 | 1993-03-01 | Hoffmann La Roche | |
FR2783828B1 (fr) | 1998-09-29 | 2000-11-10 | Synthelabo | Derives d'acide 5,6-dihydro-4h-imidazo[1,2-a][1] benzazepine -1-acetique, leur preparation et leur application en therapeutique |
ES2195943T3 (es) | 1999-11-12 | 2003-12-16 | Neurogen Corp | Compuestos heteroaromaticos biciclicos y triciclicos. |
TWI239333B (en) | 2000-11-16 | 2005-09-11 | Hoffmann La Roche | Benzodiazepine derivatives as GABA A receptor modulators |
-
2002
- 2002-04-09 US US10/118,584 patent/US6686352B2/en not_active Expired - Fee Related
- 2002-05-08 HU HU0400743A patent/HUP0400743A3/hu unknown
- 2002-05-08 NZ NZ529097A patent/NZ529097A/en unknown
- 2002-05-08 WO PCT/EP2002/005121 patent/WO2002094834A1/en active IP Right Grant
- 2002-05-08 CZ CZ20033355A patent/CZ20033355A3/cs unknown
- 2002-05-08 PT PT02771640T patent/PT1399448E/pt unknown
- 2002-05-08 BR BR0209859-8A patent/BR0209859A/pt not_active IP Right Cessation
- 2002-05-08 YU YU90003A patent/YU90003A/sh unknown
- 2002-05-08 IL IL15857202A patent/IL158572A0/xx unknown
- 2002-05-08 MX MXPA03010529A patent/MXPA03010529A/es active IP Right Grant
- 2002-05-08 AU AU2002338898A patent/AU2002338898B2/en not_active Ceased
- 2002-05-08 ES ES02771640T patent/ES2232778T3/es not_active Expired - Lifetime
- 2002-05-08 CA CA002446903A patent/CA2446903C/en not_active Expired - Fee Related
- 2002-05-08 RU RU2003136078/04A patent/RU2287531C2/ru not_active IP Right Cessation
- 2002-05-08 PL PL02366846A patent/PL366846A1/xx not_active Application Discontinuation
- 2002-05-08 SK SK1525-2003A patent/SK15252003A3/sk unknown
- 2002-05-08 DK DK02771640T patent/DK1399448T3/da active
- 2002-05-08 KR KR10-2003-7015036A patent/KR100533406B1/ko not_active IP Right Cessation
- 2002-05-08 AT AT02771640T patent/ATE283857T1/de not_active IP Right Cessation
- 2002-05-08 JP JP2002591507A patent/JP4068466B2/ja not_active Expired - Fee Related
- 2002-05-08 EP EP02771640A patent/EP1399448B1/en not_active Expired - Lifetime
- 2002-05-08 DE DE60202147T patent/DE60202147T2/de not_active Expired - Lifetime
- 2002-05-08 CN CNB028101774A patent/CN1230436C/zh not_active Expired - Fee Related
- 2002-05-08 SI SI200230055T patent/SI1399448T1/xx unknown
- 2002-05-14 JO JO200243A patent/JO2297B1/en active
- 2002-05-15 TW TW091110162A patent/TWI251489B/zh not_active IP Right Cessation
- 2002-05-15 PA PA20028545201A patent/PA8545201A1/es unknown
- 2002-05-16 AR ARP020101805A patent/AR033753A1/es not_active Application Discontinuation
- 2002-05-16 PE PE2002000413A patent/PE20030041A1/es not_active Application Discontinuation
- 2002-05-16 GT GT200200087A patent/GT200200087A/es unknown
- 2002-05-17 MY MYPI20021808A patent/MY127570A/en unknown
-
2003
- 2003-10-23 IL IL158572A patent/IL158572A/en not_active IP Right Cessation
- 2003-10-31 ZA ZA200308544A patent/ZA200308544B/en unknown
- 2003-11-04 HR HR20030890A patent/HRP20030890A2/xx not_active Application Discontinuation
- 2003-11-14 MA MA27398A patent/MA27024A1/fr unknown
- 2003-11-17 EC EC2003004851A patent/ECSP034851A/es unknown
- 2003-11-17 NO NO20035104A patent/NO20035104L/no not_active Application Discontinuation
- 2003-11-18 BG BG108369A patent/BG108369A/bg unknown
-
2004
- 2004-12-01 HK HK04109492A patent/HK1066544A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200200087A (es) | Derivados de imidazo (1,5-a) pirimido(5,4-d) (1) benzacepina | |
GT200300226A (es) | 4-piperazinilbencenosulfonilindoles y usos de los mismos | |
DK1869049T3 (da) | Imidazopyridazinforbindelser | |
PE20030129A1 (es) | Imidazotriazinas | |
ES2164657T3 (es) | Derivados aza-biciclicos puenteados como antagonistas de la sustancia p. | |
GT200100160A (es) | Derivados 4-fenil-piridina. | |
ES2111650T3 (es) | Derivados aciclicos de etilenodiamina como antagonistas de receptores de la sustancia p. | |
DE60326060D1 (de) | Nichtvernetzende pyrroloä2,1-cüä1,4übenzodiazepine als potentielle antitumor-agentien und ihre herstellung | |
CR20110095A (es) | Derivados biciclicos [3.1.0] como inhibidores del transportador de glicina (divisional solicitud 8333) | |
UY28150A1 (es) | Agentes terapeuticos | |
AR029465A1 (es) | Compuestos heterociclicos y su uso | |
MY138478A (en) | Benzazepine derivatives for the treatment of neurological disorders | |
PE20020583A1 (es) | Derivados de benzodiazepina como moduladores del receptor gaba a | |
CR10682A (es) | Compuestos de tiazol pirazolopirimidina | |
ATE477255T1 (de) | Imidazobenzdiazepinderivate | |
DK1899350T3 (da) | Pyrazolo [3,4-D]azepinderivater som histamin-H3-antagonister | |
GT200200280A (es) | Lactamas como antagonistas de taquiquininas | |
UY27232A1 (es) | Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos | |
GT200200081A (es) | Sal citrato de 5,8,14-triazatetraciclo[10.3.1.0 2,11.0 4,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de la misma | |
AR051395A1 (es) | Derivados de imidazo- benzodiazepina, composiciones farmaceuticas que los contienen, metodo de preparacion de los mismos, y usos en terapeutica | |
PA8652101A1 (es) | Compuestos de imidazo(1,2-a)piridina, composiciones, usos y métodos relacionados | |
GT200100253A (es) | Derivados de (1,2,4) triazolo (1,5-a) piridina | |
PA8558701A1 (es) | Derivados de benzotiazol | |
UY27560A1 (es) | Compuestos hexaciclicos- | |
AR047181A1 (es) | N-cicloalquil, aril o heteroaril-n??-quinolin-2-ilcicloalquildiaminas, procesos para preparar tales compuestos y composiciones farmaceuticas que las contienen |